Your browser doesn't support javascript.
loading
Structural basis of sphingosine-1-phosphate receptor 1 activation and biased agonism.
Xu, Zhenmei; Ikuta, Tatsuya; Kawakami, Kouki; Kise, Ryoji; Qian, Yu; Xia, Ruixue; Sun, Ming-Xia; Zhang, Anqi; Guo, Changyou; Cai, Xue-Hui; Huang, Zhiwei; Inoue, Asuka; He, Yuanzheng.
Afiliação
  • Xu Z; Laboratory of Receptor Structure and Signaling, The HIT Center for Life Sciences, Harbin Institute of Technology, Harbin, China.
  • Ikuta T; Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan.
  • Kawakami K; Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan.
  • Kise R; Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan.
  • Qian Y; Laboratory of Receptor Structure and Signaling, The HIT Center for Life Sciences, Harbin Institute of Technology, Harbin, China.
  • Xia R; Laboratory of Receptor Structure and Signaling, The HIT Center for Life Sciences, Harbin Institute of Technology, Harbin, China.
  • Sun MX; State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute of Chinese Academy of Agricultural Sciences, Harbin, China.
  • Zhang A; The HIT cryo-EM facility, Harbin Institute of Technology, Harbin, China.
  • Guo C; The HIT cryo-EM facility, Harbin Institute of Technology, Harbin, China.
  • Cai XH; State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute of Chinese Academy of Agricultural Sciences, Harbin, China.
  • Huang Z; HIT Center for Life Sciences, School of Life Science and Technology, Harbin Institute of Technology, Harbin, China.
  • Inoue A; Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan. iaska@tohoku.ac.jp.
  • He Y; Laboratory of Receptor Structure and Signaling, The HIT Center for Life Sciences, Harbin Institute of Technology, Harbin, China. ajian.he@hit.edu.cn.
Nat Chem Biol ; 18(3): 281-288, 2022 03.
Article em En | MEDLINE | ID: mdl-34937912
ABSTRACT
Sphingosine-1-phosphate receptor 1 (S1PR1) is a master regulator of lymphocyte egress from the lymph node and an established drug target for multiple sclerosis (MS). Mechanistically, therapeutic S1PR1 modulators activate the receptor yet induce sustained internalization through a potent association with ß-arrestin. However, a structural basis of biased agonism remains elusive. Here, we report the cryo-electron microscopy (cryo-EM) structures of Gi-bound S1PR1 in complex with S1P, fingolimod-phosphate (FTY720-P) and siponimod (BAF312). In combination with functional assays and molecular dynamics (MD) studies, we reveal that the ß-arrestin-biased ligands direct a distinct activation path in S1PR1 through the extensive interplay between the PIF and the NPxxY motifs. Specifically, the intermediate flipping of W2696.48 and the retained interaction between F2656.44 and N3077.49 are the key features of the ß-arrestin bias. We further identify ligand-receptor interactions accounting for the S1PR subtype specificity of BAF312. These structural insights provide a rational basis for designing novel signaling-biased S1PR modulators.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Cloridrato de Fingolimode / Esclerose Múltipla Limite: Humans Idioma: En Revista: Nat Chem Biol Assunto da revista: BIOLOGIA / QUIMICA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Cloridrato de Fingolimode / Esclerose Múltipla Limite: Humans Idioma: En Revista: Nat Chem Biol Assunto da revista: BIOLOGIA / QUIMICA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China